SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...

A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...

One patient contemplated whether he should fulfill his newfound gay fantasies and described his new sexual urges after ...

The MARCAP Consortium is the largest independent data repository and statistical analysis team, with Dr. Spratt and Dr. Amar Kishan as co-primary investigators. The purpose of the first MARCAP ...

BE honest: if you spot a lump, bump or change down there, are you likely to raise it with a GP or do you just hope it goes ...

Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...

CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...

Experiencing frequent rage and irritability? It could be Irritable Male Syndrome (IMS), a term gaining acceptance for ...

Scientific studies confirm that physical activity, diet, stress reduction and sleep are among the most effective driving ...

Best menopause supplements 2025, recommended by experts - Menopause experts shares their top non-negotiable supplements for ...

Stereotactic body radiation therapy (SBRT), defined as the delivery of >5Gy per fraction, has emerged as a well-established standard of care option for the definitive management of localized prostate ...